Goal-directed Therapy in Neurosurgery.

Status Completed

Clinical Trial Summary

The purpose of the study is to assess feasibility of future large randomised controled study aimed on assessment of effect of goal-directed therapy on incidence of complications in neurosurgery compared to standard care.

Clinical Trial Description

Patients undergoing neurosurgical operations are at risk of inadequate intravascular volume for several reasons. The appropriate fluid management in neurosurgery is a challenge. Goal-directed therapy has been shown to improve the outcome of patients undergoing major surgery. Current knowledge regarding effect of fluid management on patient-orientated outcomes in neurosurgery is limited. This study is designed as a pilot study with two parallel groups. Patients scheduled to planned brain surgery at the University Hospital Brno will be screened whether they meet the inclusion criteria. After obtaining informed consent, the patient will be randomized to one of the study arms. In one arm (STANDARD) standard monitoring of vital signs will be introduced. During the operation, perioperative fluid therapy and administration of vasoactive agents will depend entirely at the discretion of the attending anaesthetist. Postoperative therapy will be fully controlled and will depend on the decision of the attending physician. In the second arm (GDT), a non-invasive hemodynamic monitor STARLINK™SV will be introduced in addition to standard monitoring. In this arm, basal infusion with crystalloid balanced solution will be initiated. Additional boluses of fluids will be administered based on haemodynamic monitoring. The primary outcome of the study is a proportion of patients with serious adverse event (SAE). Incidence of SAEs will be compared between study groups. SAE will be defined as unsatisfactory brain tissue relaxation at the end of operation and any intervention for brain oedema postoperatively. The secondary outcome is to compare proportion of patients with postoperative complications in both groups and length of ICU and hospital stay. This study will enroll 34 patients in total, 17 in each group. After completion of enrolment of patients the statistical analysis will be performed. ;

Study Design

Related Conditions & MeSH terms

Surgery--Complications

Clinical Trial Details

NCT number	NCT04754295
Study type	Interventional
Source	Brno University Hospital
Contact
Status	Completed
Phase	N/A
Start date	March 1, 2021
Completion date	November 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05062564` - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye	N/A
Completed	`NCT05346588` - THRIVE Feasibility Trial	Phase 3
Completed	`NCT03930784` - A Real-world Study to Examine the Relationship Between Simple Physical Functioning Tests, Complications and Recovery Following Abdominal Surgery.
Not yet recruiting	`NCT04430972` - Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure)
Recruiting	`NCT04887415` - Respiratory Strength Training in Cardiac Surgical Patients	N/A
Recruiting	`NCT05254262` - Multicenter National Trial of Clinical Results of Surgical Elderly Patients
Recruiting	`NCT03561376` - Zinc Oxide Versus Petrolatum Following Skin Surgery	Early Phase 1
Recruiting	`NCT05155878` - Prognostic Factors in Periampullary Tumors and Cysts
Recruiting	`NCT04967391` - Tumescence in HNC Skin Graft Reconstruction	Phase 3
Terminated	`NCT03757455` - ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy	N/A
Completed	`NCT03793816` - Tonsillectomy Using BiZact™ - a Randomized Side-controlled Clinical Trial	N/A
Completed	`NCT03246165` - Predictive Factors and Complications of Delirium
Withdrawn	`NCT04090918` - Novel Methods for Characterizing Patients With Post-operative Atrial Fibrillation Secondary to Abdominal Surgery
Completed	`NCT05373238` - Same Day Discharge After Laparoscopic Hysterectomy
Completed	`NCT03938584` - The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients	N/A
Not yet recruiting	`NCT05046925` - PACU for Postoperative Care After Major Thoracic and Abdominal Surgery
Completed	`NCT04550156` - Evaluation of the Introduction of a Colorectal Bundle in Left Sided Colorectal Resections	N/A
Not yet recruiting	`NCT04199208` - Does Prehabilitation Improve Outcome in Coloncancer Surgery?	N/A
Completed	`NCT04257344` - Use of Wearables for Early Detection of Complications After Major Acute Abdominal Surgery
Active, not recruiting	`NCT03721471` - Outcome of Very Old Patients Admitted for Elective Major Surgery, the Effect of Frailty

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.